These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126 [TBL] [Abstract][Full Text] [Related]
23. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture. Shimizu D; Sato N; Sato T; Makino K; Kito M; Shirasawa H; Kumagai J; Terada Y J Obstet Gynaecol Res; 2015 Mar; 41(3):432-9. PubMed ID: 25330897 [TBL] [Abstract][Full Text] [Related]
24. Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study. Harrison ML; Hoskins P; du Bois A; Quinn M; Rustin GJ; Ledermann JA; Baron-Hay S; Friedlander ML Gynecol Oncol; 2006 Feb; 100(2):233-8. PubMed ID: 16321429 [TBL] [Abstract][Full Text] [Related]
25. Current aspects of adjuvant therapy of early stage ovarian cancer. McGuire WP Zentralbl Gynakol; 1998; 120(3):93-7. PubMed ID: 9556898 [TBL] [Abstract][Full Text] [Related]
26. Advances in the understanding and treatment of ovarian cancer. Morrison J J Br Menopause Soc; 2005 Jun; 11(2):66-71. PubMed ID: 15970018 [TBL] [Abstract][Full Text] [Related]
27. Treatment Outcomes of Epithelial Ovarian Cancers Following Maximum Cytoreduction and Adjuvant Paclitaxel-Carboplatin Chemotherapy: Egyptian NCI Experience. Nassar HR; Zeeneldin AA; Helal AM; Ismail YM; Elsayed AM; Elbassuiony MA; Moneer MM Asian Pac J Cancer Prev; 2015; 16(16):7237-42. PubMed ID: 26514517 [TBL] [Abstract][Full Text] [Related]
28. Ovarian cancer of epithelial origin--an update. Menczer J Isr J Med Sci; 1993 Aug; 29(8):477-83. PubMed ID: 8407278 [No Abstract] [Full Text] [Related]
29. [Prognostic factors in patients with stage I epithelial ovarian cancer]. Wen HW; Liu SW Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):235-7, 255. PubMed ID: 8082450 [TBL] [Abstract][Full Text] [Related]
30. Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas. Horng HC; Lai CR; Chang WH; Wen KC; Chen YJ; Juang CM; Yen MS; Wang PH Taiwan J Obstet Gynecol; 2014 Dec; 53(4):547-51. PubMed ID: 25510699 [TBL] [Abstract][Full Text] [Related]
31. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA? Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028 [TBL] [Abstract][Full Text] [Related]
32. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
33. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma. Saygili U; Guclu S; Uslu T; Erten O; Dogan E Int J Gynecol Cancer; 2002; 12(5):438-42. PubMed ID: 12366659 [TBL] [Abstract][Full Text] [Related]
34. Early-stage ovarian cancer: to treat or not to treat. Young RC J Natl Cancer Inst; 2003 Jan; 95(2):94-5. PubMed ID: 12529336 [No Abstract] [Full Text] [Related]
35. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923 [TBL] [Abstract][Full Text] [Related]
36. [Developments in the therapy of advanced FIGO III ovarian cancer]. Kuhn W; Jänicke F; Pache L; Hölscher M; Schattenmann G; Schmalfeldt B; Anderl H; Schüle G; Dettmar P; Siewert JR Geburtshilfe Frauenheilkd; 1993 May; 53(5):293-302. PubMed ID: 8514099 [TBL] [Abstract][Full Text] [Related]
37. Limited efficacy of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors. Vasconcelos I; Olschewski J; Braicu I; Sehouli J Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():26-33. PubMed ID: 25602531 [TBL] [Abstract][Full Text] [Related]
38. The treatment of early stage ovarian cancer. Young RC Semin Oncol; 1995 Oct; 22(5 Suppl 12):76-9. PubMed ID: 7481865 [TBL] [Abstract][Full Text] [Related]
39. Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women. Chishti U; Aziz AB J Pak Med Assoc; 2015 Mar; 65(3):306-9. PubMed ID: 25933567 [TBL] [Abstract][Full Text] [Related]
40. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]